Banner
Home

Three or more eggs a week increase your risk of heart disease and early death, study says Print E-mail
Written by FHI's Week in Review   
Monday, 18 March 2019 16:57
 
A study published Friday, 3/15/19 in the medical journal JAMA delivers bad news for egg lovers. According the researchers, among 29,615 adults pooled from 6 prospective cohort studies in the United States with a median follow-up of 17.5 years, each additional 300 mg of dietary cholesterol consumed per day was significantly associated with higher risk of incident CVD and all-cause mortality, and each additional half an egg consumed per day was significantly associated with higher risk of incident CVD and all-cause mortality. The researchers adjusted for the fact that egg consumption may be associated with unhealthy behaviors, such as low physical activity, smoking, or an unhealthy diet.
 
Read more in the current issue of Week in Review>> https://conta.cc/2F9RokZ
 
Last Updated on Monday, 18 March 2019 17:07
 
FL Senate Signs Off On Smokable Marijuana Print E-mail
Written by FHI's Week in Review   
Monday, 11 March 2019 18:33
 
Dara Kam reports for News Service of Florida via Health News Florida on  Mar 8, 2019:
Bowing to a demand by Gov. Ron DeSantis, the Florida Senate on Thursday <3.7.19> overwhelmingly approved a measure that would allow patients to smoke medical marijuana if doctors deem it the proper treatment. Under the proposal, patients could buy up to 2.5 ounces of medical pot during a 35-day period and would be able to possess up to 4 ounces of cannabis at any given time. Smoking of medical cannabis --- which would have to be purchased from state-authorized operators --- would be banned in public places. The Senate's 34-4 vote in favor of the measure (SB 182) came two days after the start of the 2019 legislative session, and the House is expected to take up the measure Wednesday <3.13.19>.
Read more in the current issue of Week in Review>> https://conta.cc/2EW0kdt
 
Last Updated on Monday, 11 March 2019 18:38
 
Pharma Execs Dig in for a Fight Against Outraged Senators Print E-mail
Written by Emmarie Huetteman, Jay Hancock | KHN   
Wednesday, 27 February 2019 00:00
 
Senators got their first opportunity Tuesday to prod drugmakers about the wallet-emptying prices they charge for prescription drugs. Almost in unison, the executives expressed support for eliminating rebates that flow to industry middlemen instead of patients; for increasing transparency about how they set prices; for shifting to a more value-based pricing system, in which outcomes are rewarded. Together they demurred when asked to commit to lowering list prices on drugs like insulin and the blockbuster rheumatoid arthritis drug Humira. The drugmakers - AbbVie, AstraZeneca, Bristol-Myers Squibb, Johnson & Johnson, Merck, Pfizer and Sanofi - appeared before the Senate Finance Committee as lawmakers mull how to best control rising drug prices. 
 
 
Lab to Pay $63.5M to Settle Kickback Allegations Print E-mail
Written by Vitale Health Law   
Tuesday, 05 February 2019 18:19
 
Inform Diagnostics, an Irving, Texas-based pathology laboratory company, has agreed to pay $63.5 million to settle allegations that it violated the False Claims Act by  engaging in improper financial relationships with referring physicians. The settlement stems from allegations that the company violated the Anti-Kickback Statute and the Stark Lawby providing referring physicians with subsidies for electronic health records (EHR) systems and free or discounted technology consulting services. The Anti-Kickback Statute and the Stark Law restrict the financial relationships that health care providers, including laboratories, may have with doctors who refer patients to them.
Last Updated on Tuesday, 05 February 2019 18:21
 
Sponsor Showcase Print E-mail
Written by Sponsor   
Wednesday, 27 February 2019 00:00
 
bdo-ftl hc florida-health-industry ad 1-19
Last Updated on Tuesday, 26 February 2019 18:05
 


Banner
Website design, development, and hosting provided by
Netphiles